Who are the women blaz­ing trails in bio­phar­ma R&D? Nom­i­nate them for End­points' spe­cial re­port

Gen­der im­bal­ance in the av­er­age cor­po­rate board­room is en­dem­ic, and the bio­phar­ma world is no ex­cep­tion. Da­ta sug­gest women are woe­ful­ly un­der­rep­re­sent­ed in lead­er­ship roles, hold­ing just 20% of these seats at bio­phar­ma firms.

Last year, when we asked the End­points 100 — the group of biotech ex­ecs we re­ly on to mea­sure in­dus­try-wide sen­ti­ments in a se­mi-an­nu­al sur­vey — how the in­dus­try was per­form­ing on gen­der di­ver­si­ty, there was a con­sen­sus that it could do bet­ter. One way to do this, is to en­cour­age and cel­e­brate the women who have climbed the lad­der, de­spite the odds.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER